Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research reviews two stocks that are both Zacks Rank #1 (Strong Buy) that also have growth style scores of “A.” This week Brian highlights PetMed Express (PETS - Free Report) and discusses the recent “short and distort” style report that was floated about the company a few weeks ago. Brian states that his experiences in buying medication for his pet Buckeye were the exact opposite of what the company was being accused of. Brian believes the stock is not a dog and will run higher. Crox (CROX - Free Report) is the next stock that is profiled and Brian speaks to higher earnings estimates. Terry notes that the shoes must be worn by more people than just chef’s – and Brian speaks to more types of shoes than the original being sold.
One Simple Trading Idea
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.
Learn more >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research reviews two stocks that are both Zacks Rank #1 (Strong Buy) that also have growth style scores of “A.” This week Brian highlights PetMed Express (PETS - Free Report) and discusses the recent “short and distort” style report that was floated about the company a few weeks ago. Brian states that his experiences in buying medication for his pet Buckeye were the exact opposite of what the company was being accused of. Brian believes the stock is not a dog and will run higher. Crox (CROX - Free Report) is the next stock that is profiled and Brian speaks to higher earnings estimates. Terry notes that the shoes must be worn by more people than just chef’s – and Brian speaks to more types of shoes than the original being sold.
One Simple Trading Idea
Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.
This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.
Learn more >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PETS - FREE
Get the latest research report on CROX - FREE